# Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia

> **NCT01320735** · — · COMPLETED · sponsor: **AbbVie (prior sponsor, Abbott)** · enrollment: 300 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01320735
- **Lead sponsor:** AbbVie (prior sponsor, Abbott)
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2011-02
- **Primary completion:** 2014-05
- **Final completion:** 2014-05
- **Target enrollment:** 300 (ACTUAL)
- **Last updated:** 2015-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01320735

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01320735, "Observational Program to Assess Use of Intermittent Adjuvant Deprivation Therapy With Leuprorelin (Lucrin Depot) in Patients With Advanced Prostate Cancer (PCa) in Russia". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01320735. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*